Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 2
Submit an article Journal homepage
37
Views
28
CrossRef citations to date
0
Altmetric
Brief Report

Efficacy and Tolerability of Alemtuzumab (CAMPATH-1H) in the Salvage Treatment of B-Cell Chronic Lymphocytic Leukemia—Change of Regimen Needed?

K RIEGER Medizinische Klinik III, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, GermanyCorrespondence[email protected]
,
U VON GRÜNHAGEN Onkologische Schwerpunktpraxis Cottbus, Germany
,
T FIETZ Medizinische Klinik III, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany
,
E THIEL Onkologische Schwerpunktpraxis Cottbus, Germany
&
W KNAUF Medizinische Klinik III, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany
Pages 345-349 | Received 16 Jun 2003, Published online: 03 Aug 2009

References

  • Lundin, J., Osterborg, A., Brittinger, G., Crowther, D., Dombret, H., Engert, A., et al. (1998) "Campath-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lympho-mas: a phase II multicenter study", Journal of Clinical Oncology, 16, 3257–3263.
  • Keating, M.J., Flinn, I., Jain, V., Binet, J.-L., Hillmen, P., Byrd, J., et al. (2002) "Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: result of a large international study", Blood, 99, 3554 — 3561.
  • Osterborg, A., Dyer, M.J., Bunjes, D., Pangalis, G.A., Bastion, Y., Catovsky, D., et al. (1997) "Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia", Journal of Clinical Oncology, 15, 1567 — 1574.
  • Rai, KR., Freter, CE., Mercier, MR., Cooper, B.S., Mitchell, B.S., Stadtmauer, E.A., et al. (2002) "Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received Fludarabine", Journal of Clininical Oncology, 20, 3891 — 3897.
  • Cheson, B.D., Bennett, J.M., Greyer, M., Kay, N., Keating, M.J., O'Brian, S., et al. (1996) "National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment", Blood, 87, 4990 — 4997.
  • Lundin, J., Kimby, E., Björkholm, M., Broliden, P-.A., Celsing, F., Hjalmar, V., et al. (2002) "Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)", Blood, 100, 768–773.
  • Pangalis, GA., Dimopoulous, M.N., Angelopoulou, M.K. and Siakantaris, M.P. (2000) "Campath-1H in B-chronic lymphocytic leukemia: report on a patient treated thrice in a 3 year period", Medical Oncology, 17, 70–73.
  • Rebello, P., Cwynarski, K., Varughese, M., Eades, A., Apperley, J.F. and Hale, G. (2001) "Pharmacokinetics of Campath-1H in BMT patients", Cytotherapy, 3, 261–267.
  • Thieblemont, C., Bouafia, F., Hornez, E., Hequet, 0., Arnaud, P., Espinouse, D., et al. (2002) "Maintenance therapy with monthly injection of Campath-1H in refractory chronic leukemia and NHL patients", Blood, 100, 805a.
  • Bowen, AL., Zomas, A., Emmet, E., Matutes, E., Dyer, M.J. and Catovsky, D. (1997) "Subcutaneous CAMPATH-1H in fludara-bine-resistent/relapsed chronic lymphocytic and B-prolymphocytic leukemia", British Journal of Haematology, 96, 617–619.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.